An antiviral drug used to treat Covid-19 patients could be linked to mutations in the virus, new research suggests.
The medication, molnupiravir, works by causing mutations in the virus’s genetic information, or genome, and many of these mutations will damage or kill the virus, reducing the amount of virus in the body.
